Clinical trial
Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
NCT00464945 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00464945 |
|---|---|
| Title | Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants |
| Official title | A Phase 3, Randomised,Active-Controlled ,Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumococcal Vaccines |
| Intervention type | Biological |
| Interventions | 13-valent Pneumococcal Conjugate Vaccine |
| Enrollment | 269 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 24, 2007 |
| Last update posted | Aug 15, 2012 |
| Countries | Poland |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: